Associate Director, Office of Product Evaluation and Quality
U.S. Food and Drug Administration
Silver Spring, Maryland, United States
Matt Hillebrenner is an acting Associate Director for the Office of Product Evaluation and Quality at the FDA. In this role, he is part of the core leadership team developing the novel TPLC Advisory Program (TAP) Pilot. The TAP Pilot is intended to speed patient access to high quality, safe, effective, and innovative devices through process improvements to FDA’s early interactions with device manufacturers as well as facilitation of strategic engagement between participants and critical stakeholders throughout the medical device ecosystem. Matt previously spent almost two decades in the Office of Cardiovascular Devices, where he was responsible for overseeing the regulation of a wide range of devices and leading various strategic planning efforts.
Disclosure information not submitted.